| 摘要 |
<p>The present invention relates to a composition for enteral administration comprising a quail's egg lyophilisate, characterized in that the quail's egg lyophilisate is produced in the presence of 5 to 40 % by weight of carbohydrate, based on the weight of the quail's egg content. The invention also relates to the use of quail's egg or of such a composition in the preparation of a medicament or nutritional formulation for the induction of oral tolerance in mammals, whereby the quail's egg or said composition improve the oral tolerance.</p> |
